{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:34:44Z","timestamp":1773063284866,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1120,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Hypopituitarism, including severe GH deficiency, is an almost inevitable outcome of craniopharyngioma. However, some GH deficient children with this tumour may grow normally or even have accelerated growth postoperatively. To study this phenomenon we have investigated the endocrine status, including IGF\u20101 and its binding proteins IGFBP\u20101 and IGFBP3, in children referred for follow\u2010up at various time intervals after surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS<\/jats:title><jats:p>Twenty\u2010five patients (14 boys and 11 girls, aged 3.8\u201318.9 years), were studied on 34 occasions between 0.5 to 10.8 years after surgery. The tumour was intrasellar in 11 cases and suprasellar in 14.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Height and height velocity were recorded as SDS values. Body mass index (BMI) was calculated as weight\/height<jats:sup>2<\/jats:sup>. GH secretory status was evaluated by stimulation both with oral clonidine and with GH releasing hormone. Serum insulin (INS) levels were studied following an oral glucose load. IGF\u20101, IGFBP\u20103, IGFBP\u20101 and prolactin serum concentrations were evaluated in fasting samples. All hormones were measured by radioimmunoassay.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>All patients had growth hormone (GH) deficiency. Height (HtSDS<jats:sub>CA<\/jats:sub>) and height velocity SDS for chronological age (HVSDS<jats:sub>CA<\/jats:sub>) decreased progressively after surgery (r\u2003=\u2003\u20130.47, <jats:italic>P<\/jats:italic>\u2003=\u20030.005, and r\u2003=\u2003\u20130.4, <jats:italic>P<\/jats:italic>\u2003=\u20030.032, respectively) but four patients had normal HtSDS<jats:sub>CA<\/jats:sub> 6.1 to 10.8 years following their first surgery.<\/jats:p><jats:p>There was a significant correlation between BMI and HtSDS<jats:sub>CA<\/jats:sub> (r\u2003=\u20030.37, <jats:italic>P<\/jats:italic>\u2003=\u20030.03). BMI in children with suprasellar craniopharyngioma was significantly greater than that in patients with intrasellar tumour (23.3\u2003\u00b1\u20037.0 <jats:italic>vs<\/jats:italic>. 17.3\u2003\u00b1\u20031.4\u2003kg\/m<jats:sup>2<\/jats:sup>; <jats:italic>P<\/jats:italic>\u2003=\u20030.001). In 13 of 33 cases oral glucose load was accompanied by hyperinsulinaemia with serum INS levels greater than 50\u2003mU\/l. The mean area under the curve (AUC) of INS after glucose load (INS<jats:sub>AUC<\/jats:sub>) in the suprasellar group was greater than in the patients with intrasellar lesion (6945.5\u2003\u00b1\u20034411.8 <jats:italic>vs<\/jats:italic>. 2495.5\u2003\u00b1\u20031768.8\u2003mU\/l. min <jats:italic>P<\/jats:italic>\u2003=\u20030.001). The log INS<jats:sub>AUC<\/jats:sub> correlated significantly with HtSDS<jats:sub>CA<\/jats:sub> (0.37, <jats:italic>P<\/jats:italic>\u2003=\u20030.03). Fasting serum IGF\u20101 and IGFBP3 levels were normal in 8 and 12 of the 31 measurements, respectively. Both IGF\u20101SDS and IGFBP\u20103SDS correlated significantly with HtSDS<jats:sub>CA<\/jats:sub> (r\u2003=\u20030.77, <jats:italic>P<\/jats:italic>\u2003=\u20030.0002 and r\u2003=\u20030.65, <jats:italic>P<\/jats:italic>\u2003=\u20030.0001, respectively) and the log INS<jats:sub>AUC<\/jats:sub> (r\u2003=\u20030.39, <jats:italic>P<\/jats:italic>\u2003=\u20030.035, r\u2003=\u20030.56, <jats:italic>P<\/jats:italic>\u2003=\u20030.002, respectively). As determined by forward stepwise regression analysis, IGF\u20101<jats:sub>SDS<\/jats:sub> was the single most important predictor of HtSDS<jats:sub>CA<\/jats:sub> (R<jats:sup>2<\/jats:sup>\u2003=\u20030.33, <jats:italic>P<\/jats:italic>\u2003=\u20030.001) in the subset mode.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>A few children with craniopharyngioma grew normally after surgery, in spite of being GH\u2010deficient. This growth phenomenon, which is usually accompanied by obesity, was more common in patients with suprasellar tumour and is likely to be associated with the effect of IGF\u20101 bioavailability, which, in turn, may be modulated largely by insulin.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.00590.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:39:12Z","timestamp":1047379152000},"page":"733-738","source":"Crossref","is-referenced-by-count":45,"title":["Growth in children with craniopharyngioma following surgery"],"prefix":"10.1111","volume":"49","author":[{"given":"A. N.","family":"Tiulpakov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A.","family":"Mazerkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G. D.","family":"Brook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.","family":"Hindmarsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. A.","family":"Peterkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Gorelyshev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1986.65.1.0022"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-198607000-00004"},{"key":"e_1_2_6_4_2","unstructured":"Blum W.F.(1992)Insulin\u2010like growth factors and their binding proteins. InFunctional endocrinologic diagnostics in children and adolescents. (ed M.B. Ranke) J & J Verlag Mannheim pp102\u2013108."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.3.872"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198311103091902"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-4-731"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.6.1355"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-98-5-1214"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.7.2734"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1976.tb01984.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","unstructured":"Greulich W.W.&Pyle S.I.(1959)Radiographic atlas of skeletal development of the hand and wrist. 2nd edn. Stanford University Press Stanford CA.","DOI":"10.1097\/00000441-195909000-00030"},{"key":"e_1_2_6_13_2","first-page":"259","article-title":"Standardized percentile curves of body mass index for children and adolescents","volume":"145","author":"Hammer L.D.","year":"1991","journal-title":"American Journal of Diseases of Childhood"},{"key":"e_1_2_6_14_2","first-page":"141","article-title":"Combined anterior pituitary function test using CRH, GRH, LH\u2010RH, TRH and vasopressin in patients with non\u2010functioning pituitary tumors","volume":"44","author":"Hashimoto K.","year":"1990","journal-title":"Acta Medica Okayama"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-12-3-235"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-204-43630"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.23.3.203"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000182272"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-82-3-493"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-2-255"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92437-6"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1988.tb10705.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.51.3.170"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00590.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00590.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.00590.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T03:29:00Z","timestamp":1698463740000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.00590.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1046\/j.1365-2265.1998.00590.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00590.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}